The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that the rising tide did not actually lift all ships. There were over…
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical stocks, short interest was lower.
The short interest data for the July 29 settlement date are out and it almost feels like short sellers are getting a bit panicked about the market rally.
August 8, 2016: Markets opened higher Monday but turned south shortly after the opening bell and remained in the red for the rest of the day. The dollar gained strength this afternoon…
Allergan reported mixed second-quarter 2016 results and announced share buybacks before markets opened Monday morning.
August 2, 2016: Markets opened nearly flat again Tuesday on stronger oil prices early in the day before reality set in. As it is, energy is the sole sector that trades higher…
When Pfizer reported its second-quarter financial results before the markets opened on Tuesday, investors initially did not appear impressed.
Chris Lange The upcoming earnings report will showcase what Pfizer has to offer for the second half of 2016, and potentially give some insight into what companies it may be looking to pursue next.
Chris Lange 24/7 Wall St. has put together a preview of Pfizer, Chesapeake Energy and other major companies reporting their quarterly results this week.
The short interest data have been released for the July 15 settlement date. For the selected pharmaceutical stocks, short interest was mixed.
With yields plunging and the market getting very pricey, some top pharmaceutical stocks are starting to look like a great total return vehicle for the rest of this year and into 2017.
July 14, 2016: Markets opened higher again Thursday after producer prices came in higher than expected for June and new claims for unemployment benefits came in lower than expected. The three major…
With many stocks having just hit record highs, investors need at least a bit of an explanation here. One thing likely contributing to the gains is the endless effort in share buybacks…
The June 30 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest decreased.
Viagra, the wildly successful erectile dysfunction pill, faces challenges from a generic version that will launch next year.
